Robert F Doman - Net Worth and Insider Trading
Robert F Doman Net Worth
The estimated net worth of Robert F Doman is at least $5 Million dollars as of 2024-04-25. Robert F Doman is the President and CEO, Director of Davis Select U.S. Equity ETF and owns about 130,000 shares of Davis Select U.S. Equity ETF (DUSA) stock worth over $5 Million. Details can be seen in Robert F Doman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Robert F Doman has not made any transactions after 2008-08-22 and currently still holds the listed stock(s).
Transaction Summary of Robert F Doman
Robert F Doman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Robert F Doman owns 2 companies in total, including Akari Therapeutics PLC (AKTX) , and Echo Therapeutics Inc (ECTE) .
Click here to see the complete history of Robert F Doman’s form 4 insider trades.
Insider Ownership Summary of Robert F Doman
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AKTX | Akari Therapeutics PLC | 2015-01-01 | director |
| ECTE | Echo Therapeutics Inc | 2013-10-01 | director & EXEC. CHAIRMAN AND INTERIM CEO |
Robert F Doman Latest Holdings Summary
Robert F Doman currently owns a total of 1 stock. Robert F Doman owns 130,000 shares of Davis Select U.S. Equity ETF (DUSA) as of August 22, 2008, with a value of $5 Million.
Latest Holdings of Robert F Doman
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| DUSA | Davis Select U.S. Equity ETF | 2008-08-22 | 130,000 | 38.66 | 5,025,800 |
Holding Weightings of Robert F Doman
Robert F Doman Form 4 Trading Tracker
According to the SEC Form 4 filings, Robert F Doman has made a total of 0 transactions in Davis Select U.S. Equity ETF (DUSA) over the past 5 years. The most-recent trade in Davis Select U.S. Equity ETF is the acquisition of 5,000 shares on August 22, 2008, which cost Robert F Doman around $8,650.
Insider Trading History of Robert F Doman
- 1
Robert F Doman Trading Performance
Robert F Doman Ownership Network
Ownership Network List of Robert F Doman
Ownership Network Relation of Robert F Doman
Robert F Doman Owned Company Details
What does Akari Therapeutics PLC do?
Who are the key executives at Akari Therapeutics PLC?
Robert F Doman is the director of Akari Therapeutics PLC. Other key executives at Akari Therapeutics PLC include General Counsel and Secretary Robert M Shaw , director & 10 percent owner James Hill , and director & 10 percent owner Stuart Ungar .
Akari Therapeutics PLC (AKTX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Akari Therapeutics PLC (AKTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Akari Therapeutics PLC (AKTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Akari Therapeutics PLC (AKTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Akari Therapeutics PLC Insider Transactions
Robert F Doman Mailing Address
Above is the net worth, insider trading, and ownership report for Robert F Doman. You might contact Robert F Doman via mailing address: C/o Dusa Pharmaceuticals, Inc., 25 Upton Drive, Wilmington Ma 01887.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
